OTCMKTS:ADOCY Adocia (ADOCY) Stock Price, News & Analysis $11.80 0.00 (0.00%) As of 09/11/2026 Add Compare Share Share Stock Analysis Stock AnalysisChart About Adocia Stock (OTCMKTS:ADOCY) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Adocia alerts:Sign Up Key Stats Today's Range$11.80▼$11.8050-Day Range$11.80▼$11.8052-Week Range$9.80▼$11.80VolumeN/AAverage VolumeN/AMarket Capitalization$238.95 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Adocia is a clinical‐stage biotechnology company focused on the development of innovative formulations of therapeutic proteins for metabolic diseases, most notably diabetes. The company’s proprietary BioChaperone® platform uses small molecular excipients to stabilize and optimize the pharmacokinetic and pharmacodynamic properties of peptides and proteins. Adocia’s primary area of research centers on improving the onset, duration and patient convenience of insulin and other hormone therapies. Adocia’s pipeline includes a range of investigational products designed to address unmet needs in both type 1 and type 2 diabetes. Lead candidates feature ultra‐rapid insulin and long‐acting insulin analogs formulated to achieve faster absorption and more consistent blood glucose control. The company is also exploring combination therapies that pair insulin with other peptide hormones, as well as once‐weekly formulations of existing treatments. Clinical trials have been conducted in Europe, North America and Asia, demonstrating the platform’s versatility across multiple therapeutic areas. Founded in 2004 and headquartered in Lyon, France, Adocia leverages partnerships with global pharmaceutical companies to advance its programs toward commercialization. The company maintains a multidisciplinary team of research, regulatory and clinical experts who oversee studies in key markets worldwide. Adocia’s collaborations and licensing agreements are designed to accelerate late‐stage development, manufacture scalable drug formulations and prepare for market entry in major geographies.AI Generated. May Contain Errors. Read More Receive ADOCY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Adocia and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ADOCY Stock News HeadlinesAdocia Reports Updated Share Capital and Voting Rights for August 2026September 10, 2026 | tipranks.comAdocia reshapes board to bolster strategy in diabetes and obesitySeptember 1, 2026 | tipranks.comHow options let you do more with less capitalWould you rather spend $5,000 buying 100 shares of a $50 stock, or control those same 100 shares for a fraction of the cost? That's the core advantage options offer traders at every level. The Beginner's Guide to Options breaks down leverage, income strategies, and real trade examples in plain English — including a little-known approach many traders use to reduce costs and improve profit potential. Download your free copy before this offer expires.September 14 at 1:00 AM | Base Camp Trading (Ad)Adocia Updates Share Capital and Voting Rights After New Share IssuanceAugust 24, 2026 | tipranks.comAdocia Extends Cash Runway as BioChaperone and AdoXLong Platforms Advance in Diabetes and ObesityJuly 23, 2026 | tipranks.comAdocia raises €9.7 million in private placement, extending cash runway to Q2 2026February 26, 2025 | msn.comADOCIA Announces the Release of Its Universal Registration Document for the Year 2023April 29, 2024 | finance.yahoo.comADOCIA Announces Full Year 2023 Financial Results and Provides a Corporate and Financial UpdateApril 26, 2024 | finance.yahoo.comSee More Headlines ADOCY Stock Analysis - Frequently Asked Questions How have ADOCY shares performed this year? Adocia's stock was trading at $11.80 on January 1st, 2026. Since then, ADOCY shares have increased by 0.0% and is now trading at $11.80. How do I buy shares of Adocia? Shares of ADOCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today9/14/2026Next Earnings (Estimated)9/24/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolOTCMKTS:ADOCY CIKN/A Webwww.adocia.com Phone33-04-72-61-06-10Fax33-04-72-36-39-67Employees78Year Founded2005Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio4.18 Current Ratio1.19 Quick Ratio1.17 Sales & Book Value Annual Sales$4.35 million Price / Sales54.93 Cash FlowN/A Price / Cash FlowN/A Book Value$0.09 per share Price / Book131.11Miscellaneous Outstanding Shares20,250,000Free FloatN/AMarket Cap$238.95 million OptionableNot Optionable Beta-0.10 Social Links 7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (OTCMKTS:ADOCY) was last updated on 9/14/2026 by MarketBeat.com Staff. From Our PartnersThe only 5 stocks that matterSpaceX's IPO reportedly minted 4,400 new millionaires, and OpenAI is said to be eyeing a 1 trillion dollar IPO...TradeSmith | SponsoredThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredAmerican retirees will miss THIS. Big Banks just moved in.Central banks spent nearly $130 billion on physical gold last year, on top of $145 billion the year before. Q1...Cedar Gold Group | SponsoredEvery Major Market Reset Had These 3 Warning Signs First. All 3 Are Flashing Right Now.U.S. debt is closing in on 38 trillion as foreign buyers pull back, tightening liquidity across markets. Th...Golden Crest Metals | SponsoredHow options let you do more with less capitalWould you rather spend $5,000 buying 100 shares of a $50 stock, or control those same 100 shares for a fractio...Base Camp Trading | SponsoredMy next big call (under $1)17,556% on KDA. Here's what I'm buying now. It's a coin under $1.00 that most investors have never heard of...Crypto 101 Media | SponsoredThe 2026 beginners Guide to Gold IRAsGold trades near record highs while silver just topped $81 an ounce for the first time ever. Thousands of A...Goldco Direct, LLC | SponsoredBlackRock and Vanguard already own THISInstitutions own roughly 88 percent of an overlooked American oil and natural gas company. BlackRock holds 32 ...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adocia Please log in to your account or sign up in order to add this asset to your watchlist. Share Adocia With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
